Funds holding Aura Biosciences Inc
ISIN US05153U1079 · United States
- Fund holders
- 139
- Of which ETFs
- 29 110 other funds
- Value held
- ≈ 81.7M $ 81.3M $ · 323.9K €
- Share of capital
- 11.0 % of 103.7M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares Russell 2000 High Income ETF ProShares Trust | 2,119 | 15.8K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 2,107 | 14.8K $ | 0.00 % | as of Jul 31, 2026 ↗ | |
| PGIM Balanced Fund Prudential Investment Portfolios, Inc. | 2,100 | 14.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,795 | 13.4K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 1,708 | 12.1K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 1,676 | 12.5K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 1,657 | 12.4K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,503 | 10.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,446 | 10.8K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 1,431 | 10.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,268 | 9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,195 | 8.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,096 | 7.8K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,069 | 7.6K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 987 | 7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 820 | 5.8K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 577 | 4K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Enhanced Small Cap Value ETF Fidelity Covington Trust | 550 | 3.9K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 478 | 3.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 407 | 2.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 388 | 2.8K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 383 | 2.7K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 338 | 2.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 336 | 2.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 274 | 1.9K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 241 | 1.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 184 | 1.3K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 120 | 852 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 111 | 788.1 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 67 | 469.7 $ | 0.00 % | as of Jul 31, 2026 ↗ | |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 66 | 468.6 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity Covington Trust | 50 | 355 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 42 | 313.7 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 38 | 266.4 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 13 | 97.1 $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 13 | 92.3 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| AQR Small Cap Multi-Style Fund AQR Funds | 1 | 7.1 $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 231.2K € | 0.62 % | as of Dec 31, 2025 ↗ | ||
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 92.8K € | 0.11 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.73 % | as of Jul 31, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 0.64 % | as of May 31, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 0.63 % | as of May 31, 2026 ↗ |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 0.62 % | as of Dec 31, 2025 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.47 % | as of Jul 31, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 0.17 % | as of Jul 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.11 % | as of Dec 31, 2025 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.07 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Value ETF Fidelity Covington Trust | 0.06 % | as of Jun 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 0.06 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 137 | +15 | 11,404,398 | +43.8 % |
| 2026Q2 | 122 | -2 | 7,932,144 | +1.3 % |
| 2026Q1 | 124 | -1 | 7,828,637 | +4.8 % |
| 2025Q4 | 125 | +1 | 7,471,593 | +2.2 % |
| 2025Q3 | 124 | +6 | 7,307,308 | -0.5 % |
| 2025Q2 | 118 | +4 | 7,343,160 | -34.2 % |
| 2025Q1 | 114 | +4 | 11,157,357 | -10.9 % |
| 2024Q4 | 110 | +2 | 12,518,077 | +6.4 % |
| 2024Q3 | 108 | +5 | 11,768,368 | +3.0 % |
| 2024Q2 | 103 | +3 | 11,426,890 | +4.3 % |
| 2024Q1 | 100 | +5 | 10,952,963 | +70.2 % |
| 2023Q4 | 95 | 6,434,946 |
Institutional managers
119 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Matrix Capital Management Company, LP | 6,922,870 | 46.3M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 5,100,000 | 34.1M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,881,125 | 32.7M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 4,619,582 | 30.9M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,372,884 | 29.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,586,640 | 24M $ | as of Mar 31, 2026 |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | 20.3M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 2,117,697 | 14.2M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,072,726 | 13.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,310,862 | 8.8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,097,627 | 7.3M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 964,670 | 6.5M $ | as of Mar 31, 2026 |
| LEVIN CAPITAL STRATEGIES, L.P. | 941,400 | 6.3M $ | as of Mar 31, 2026 |
| B Group, Inc. | 597,576 | 4M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 595,744 | 4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 558,158 | 3.7M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 557,654 | 3.7M $ | as of Mar 31, 2026 |
| Regency Capital Management Inc.\DE | 532,495 | 3.6M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 430,522 | 2.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 415,191 | 2.8K $ | as of Mar 31, 2026 |
| Caligan Partners LP | 229,864 | 1.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 224,041 | 1.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 178,726 | 1.2M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 127,543 | 853.3K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 125,356 | 838.6K $ | as of Mar 31, 2026 |
Declared shareholders of Aura Biosciences Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Adage Capital Management, L.P. and 2 others | 8.44 % | 9,104,294 | as of Jun 30, 2026 · SCHEDULE 13G |
| Frazier Life Sciences Public Fund, L.P. and 13 others | 5.60 % | 5,807,260 | as of Jun 30, 2026 · SCHEDULE 13G |
| LONG FOCUS CAPITAL MANAGEMENT, LLC and 1 other | 4.90 % | 5,119,582 | as of Jun 30, 2026 · SCHEDULE 13G |
| BlackRock, Inc. | 4.40 % | 4,582,436 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Aura Biosciences Inc". https://titelia.com/en/stocks/aura-biosciences-inc-US05153U1079